Professor Paul Workman
Professor Paul Workman was appointed in a total of 7 companies and resigned from 4 of these appointments.
Role
Director
Country Of Residence
England
Nationality
British
Date of Birth
March 1952
Occupations
Scientist • Chief Executive Officer • None • Chief Executive • Company Director • Professor Of Pharmacology
Active
3
Resigned
4
Dissolved
0
Other
0
Total
7
Companies
| Company | Timeline | Status | |
| Derwentwater Associates Limited Director • Scientist | 9 Dec 2023←1 Year 10 Months→Current | Active | |
| ICR Chemical Probes Portal Limited Director • Chief Executive Officer | 11 Nov 2020←4 Years→Current | Active | |
| Storm Therapeutics Limited Director • None | 20 Sep 2017←8 Years→Current | Active | |
| Institute Of Cancer Research: Royal Cancer Hospital (The) Director • Chief Executive | 1 Jul 2014←7 Years→31 Aug 2021 | Active | |
| Macrotarg Limited Director • Company Director | 1 Feb 2008←2 Years 1 Month→31 Mar 2010 | Dissolved | |
| Piramed Limited Director • Professor Of Pharmacology | 22 Oct 2001←1 Year 5 Months→3 Apr 2003 | Active | |
| Chroma Therapeutics Limited Director • Director | 19 Sep 2001←8 Years→31 Mar 2010 | Liquidation | |
Mutual People
- Professor Michael Derek WaterfieldInstitute Of Cancer Research: Royal Cancer Hospital (The) and Piramed Limited are mutual companies.
- DR Steven John PowellMacrotarg Limited and Chroma Therapeutics Limited are mutual companies.
- Peter Vance AllenMacrotarg Limited and Chroma Therapeutics Limited are mutual companies.
- DR Susan Elizabeth FodenPiramed Limited and Institute Of Cancer Research: Royal Cancer Hospital (The) are mutual companies.
- Professor Stephen NeidleInstitute Of Cancer Research: Royal Cancer Hospital (The) is a mutual company.
- Professor Robert John OTTInstitute Of Cancer Research: Royal Cancer Hospital (The) is a mutual company.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
